Published in Pharmacogenomics on January 01, 2012
Pharmacogenetic approaches in the treatment of alcohol use disorders: addressing clinical utility and implementation thresholds. Addict Sci Clin Pract (2014) 0.79
Experimental psychopathology paradigms for alcohol use disorders: Applications for translational research. Behav Res Ther (2016) 0.75
An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study. Arch Gen Psychiatry (2008) 4.91
Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci U S A (1998) 4.67
A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology (2003) 3.66
Genetic and environmental contributions to alcohol abuse and dependence in a population-based sample of male twins. Am J Psychiatry (1999) 3.38
An 8-year follow-up of 450 sons of alcoholic and control subjects. Arch Gen Psychiatry (1996) 3.02
Rewarding, stimulant, and sedative alcohol responses and relationship to future binge drinking. Arch Gen Psychiatry (2011) 2.71
Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study. Arch Gen Psychiatry (2007) 2.28
A polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans. Alcohol Clin Exp Res (2004) 2.25
A genetic determinant of the striatal dopamine response to alcohol in men. Mol Psychiatry (2010) 2.02
Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study. Alcohol Clin Exp Res (2007) 1.86
ALDH2, ADH1B, and ADH1C genotypes in Asians: a literature review. Alcohol Res Health (2007) 1.83
Pharmacogenetic approaches to the treatment of alcohol addiction. Nat Rev Neurosci (2011) 1.74
Pharmacogenetic approach at the serotonin transporter gene as a method of reducing the severity of alcohol drinking. Am J Psychiatry (2011) 1.69
Subjective responses to alcohol consumption as endophenotypes: advancing behavioral genetics in etiological and treatment models of alcoholism. Subst Use Misuse (2010) 1.39
The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review. Alcohol Clin Exp Res (2011) 1.18
Endogenous opioids and addiction to alcohol and other drugs of abuse. Curr Top Med Chem (2009) 1.18
Alcoholism: the dissection for endophenotypes. Dialogues Clin Neurosci (2005) 1.16
Pharmacogenetics of alcohol and alcohol dependence treatment. Curr Pharm Des (2010) 1.05
Pharmacogenetics of naltrexone in asian americans: a randomized placebo-controlled laboratory study. Neuropsychopharmacology (2011) 1.05
Ethical concerns related to developing pharmacogenomic treatment strategies for addiction. Addict Sci Clin Pract (2011) 0.82
Delayed reward discounting and addictive behavior: a meta-analysis. Psychopharmacology (Berl) (2011) 3.57
Alcohol demand, delayed reward discounting, and craving in relation to drinking and alcohol use disorders. J Abnorm Psychol (2010) 2.27
Further validation of a cigarette purchase task for assessing the relative reinforcing efficacy of nicotine in college smokers. Exp Clin Psychopharmacol (2008) 1.95
Cognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trials. J Stud Alcohol Drugs (2009) 1.94
Neural activation during inhibition predicts initiation of substance use in adolescence. Drug Alcohol Depend (2011) 1.53
Alcohol use and protective sexual behaviors among high-risk adolescents. J Stud Alcohol Drugs (2007) 1.51
Latent structure of facets of alcohol reinforcement from a behavioral economic demand curve. Psychopharmacology (Berl) (2008) 1.50
Behavioral economic analysis of cue-elicited craving for alcohol. Addiction (2010) 1.33
Relations between anhedonia and smoking motivation. Nicotine Tob Res (2009) 1.24
Anhedonia and amotivation in psychiatric outpatients with fully remitted stimulant use disorder. Am J Addict (2008) 1.20
A longitudinal examination of adolescent response inhibition: neural differences before and after the initiation of heavy drinking. Psychopharmacology (Berl) (2013) 1.14
Subjective response to alcohol among alcohol-dependent individuals: effects of the μ-opioid receptor (OPRM1) gene and alcoholism severity. Alcohol Clin Exp Res (2012) 1.12
Recent binge drinking predicts smaller cerebellar volumes in adolescents. Psychiatry Res (2012) 1.07
Fronto-striatal functional connectivity during response inhibition in alcohol dependence. Addict Biol (2012) 1.05
Pharmacogenetics of naltrexone in asian americans: a randomized placebo-controlled laboratory study. Neuropsychopharmacology (2011) 1.05
Atypical neural activity during inhibitory processing in substance-naïve youth who later experience alcohol-induced blackouts. Drug Alcohol Depend (2012) 1.04
The relationship between measures of impulsivity and alcohol misuse: an integrative structural equation modeling approach. Alcohol Clin Exp Res (2011) 1.03
Anhedonia associated with stimulant use and dependence in a population-based sample of American adults. Exp Clin Psychopharmacol (2010) 0.98
The neuroeconomics of nicotine dependence: a preliminary functional magnetic resonance imaging study of delay discounting of monetary and cigarette rewards in smokers. Psychiatry Res (2012) 0.98
White matter characterization of adolescent binge drinking with and without co-occurring marijuana use: a 3-year investigation. Psychiatry Res (2013) 0.97
Understanding naltrexone mechanism of action and pharmacogenetics in Asian Americans via behavioral economics: a preliminary study. Exp Clin Psychopharmacol (2012) 0.97
Refining the depression-nicotine dependence link: patterns of depressive symptoms in psychiatric outpatients with current, past, and no history of nicotine dependence. Addict Behav (2008) 0.97
Quetiapine improves response inhibition in alcohol dependent patients: a placebo-controlled pilot study. Pharmacol Biochem Behav (2011) 0.96
Varenicline, low dose naltrexone, and their combination for heavy-drinking smokers: human laboratory findings. Psychopharmacology (Berl) (2014) 0.95
The effects of drinking goal on treatment outcome for alcoholism. J Consult Clin Psychol (2012) 0.93
Human laboratory paradigms in alcohol research. Alcohol Clin Exp Res (2012) 0.92
Genetic and environmental influences on the association between depressive symptom dimensions and smoking initiation among Chinese adolescent twins. Nicotine Tob Res (2011) 0.89
White matter integrity pre- and post marijuana and alcohol initiation in adolescence. Brain Sci (2013) 0.89
Initial evidence that OPRM1 genotype moderates ventral and dorsal striatum functional connectivity during alcohol cues. Alcohol Clin Exp Res (2013) 0.88
Risk-taking and alcohol use disorders symptomatology in a sample of problem drinkers. Exp Clin Psychopharmacol (2011) 0.87
The effects of varenicline on stress-induced and cue-induced craving for cigarettes. Drug Alcohol Depend (2013) 0.86
Varenicline, naltrexone, and their combination for heavy-drinking smokers: preliminary neuroimaging findings. Am J Drug Alcohol Abuse (2014) 0.85
Dimensions of impulsivity among heavy drinkers, smokers, and heavy drinking smokers: singular and combined effects. Addict Behav (2012) 0.83
Behavioral economic analysis of stress effects on acute motivation for alcohol. J Exp Anal Behav (2014) 0.83
Binge eating and binge drinking: an integrative review. Eat Behav (2011) 0.82
COMT Val158Met, BDNF Val66Met, and OPRM1 Asn40Asp and methamphetamine dependence treatment response: preliminary investigation. J Clin Psychopharmacol (2012) 0.80
The effect of alcohol priming on neural markers of alcohol cue-reactivity. Am J Drug Alcohol Abuse (2015) 0.79
The Serotonin Transporter Polymorphism (5-HTTLPR) and Alcohol Problems in Heavy Drinkers: Moderation by Depressive Symptoms. Front Psychiatry (2011) 0.79
Interactive effects of OPRM1 and DAT1 genetic variation on subjective responses to alcohol. Alcohol Alcohol (2014) 0.79
Blood glucose level, alcohol heavy drinking, and alcohol craving during treatment for alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) Study. Alcohol Clin Exp Res (2009) 0.79
Craving and subjective responses to alcohol administration: validation of the desires for alcohol questionnaire in the human laboratory. J Stud Alcohol Drugs (2013) 0.78
Predictors of smoking lapse in a human laboratory paradigm. Psychopharmacology (Berl) (2014) 0.78
Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol. Pharmacol Biochem Behav (2012) 0.78
Sex moderates stress reactivity in heavy drinkers. Addict Behav (2013) 0.78
Alcohol use following an alcohol challenge and a brief intervention among alcohol-dependent individuals. Am J Addict (2013) 0.77
Modeling alcohol use disorder severity: an integrative structural equation modeling approach. Front Psychiatry (2013) 0.77
A prospective study of stress and alcohol craving in heavy drinkers. Pharmacol Biochem Behav (2012) 0.76
Sex Differences in the Association Between Internalizing Symptoms and Craving in Methamphetamine Users. J Addict Med (2016) 0.75
New approaches to identifying rare genetic variants associated with nicotine dependence. Biol Psychiatry (2011) 0.75
Young Investigator Award symposium. Alcohol (2009) 0.75